Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zai Lab Ltd

29.51
+0.67002.32%
Volume:427.94K
Turnover:12.51M
Market Cap:3.24B
PE:-11.36
High:29.64
Open:28.64
Low:28.63
Close:28.84
Loading ...

Zai Lab's Cancer Drug Application Accepted by Chinese Regulator

MT Newswires Live
·
Yesterday

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors

Business Wire
·
Yesterday

All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy

Zacks
·
16 Apr

Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?

Zacks
·
14 Apr

Press Release: Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025

Dow Jones
·
14 Apr

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout

Insider Monkey
·
11 Apr

Zai Lab (ZLAB) Gets a Buy from Scotiabank

TIPRANKS
·
07 Apr

Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

MT Newswires Live
·
01 Apr

Spotlight On High Growth Tech Stocks In The US March 2025

Simply Wall St.
·
31 Mar

Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

MT Newswires Live
·
27 Mar

Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.
·
27 Mar

Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
26 Mar

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting

Business Wire
·
26 Mar

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?

Insider Monkey
·
14 Mar

Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer

TipRanks
·
14 Mar

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)

TIPRANKS
·
13 Mar

JPMorgan Adjusts Price Target on Zai Lab to $51 From $44, Keeps Overweight Rating

MT Newswires Live
·
13 Mar

Zai Lab's Tivdak Marketing Application Accepted in China for Cervical Cancer Treatment

MT Newswires Live
·
13 Mar

Zai Lab (ZLAB) Initiated with a Buy at Scotiabank

TIPRANKS
·
10 Mar

Zai Lab Initiated at Sector Outperform by Scotiabank

Dow Jones
·
08 Mar